Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma - PubMed (original) (raw)
. 2002 May 1;99(9):3398-403.
doi: 10.1182/blood.v99.9.3398.
Affiliations
- PMID: 11964309
- DOI: 10.1182/blood.v99.9.3398
Free article
Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma
Franziska Jundt et al. Blood. 2002.
Free article
Abstract
Notch signaling controls cell fate decisions of hematopoietic progenitors by inhibiting certain steps of differentiation and inducing either self-renewal or differentiation toward lymphoid or myeloid lineages. In addition, truncated Notch1 alleles could be associated with 10% of all cases of human T lymphoblastic leukemia and, when introduced into mouse bone marrow stem cells, cause T-cell neoplasms. However, functional links between the abundant expression of intact Notch1 and oncogenesis are still lacking. Here we show that Notch1 is highly expressed in B- and T-cell-derived tumor cells of Hodgkin and anaplastic large cell lymphoma. We demonstrate a novel mechanism for the oncogenic capacity of Notch1 by showing that the interaction between intact Notch1 on tumor cells and its ligand Jagged1 dramatically induces proliferation and inhibition of apoptosis in vitro. We further provide evidence that in Hodgkin and anaplastic large cell lymphoma, Jagged1 is expressed in malignant and in bystander cells colocalizing with Notch1-positive tumor cells. Notch1 signaling may therefore be activated in tumor cells by Jagged1 through homotypic or heterotypic cell-cell interactions, and it seems likely that these interactions contribute to lymphomagenesis in vivo. Thus, our data suggest that activated Notch1 signaling plays an important role in the pathobiology of Hodgkin and anaplastic large cell lymphoma and that it might be a potential new target for treatment.
Similar articles
- Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
Jundt F, Pröbsting KS, Anagnostopoulos I, Muehlinghaus G, Chatterjee M, Mathas S, Bargou RC, Manz R, Stein H, Dörken B. Jundt F, et al. Blood. 2004 May 1;103(9):3511-5. doi: 10.1182/blood-2003-07-2254. Epub 2004 Jan 15. Blood. 2004. PMID: 14726396 - Soluble Jagged-1 is able to inhibit the function of its multivalent form to induce hematopoietic stem cell self-renewal in a surrogate in vitro assay.
Vas V, Szilágyi L, Pálóczi K, Uher F. Vas V, et al. J Leukoc Biol. 2004 Apr;75(4):714-20. doi: 10.1189/jlb.1003462. Epub 2004 Jan 23. J Leukoc Biol. 2004. PMID: 14742638 - Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development.
Felli MP, Maroder M, Mitsiadis TA, Campese AF, Bellavia D, Vacca A, Mann RS, Frati L, Lendahl U, Gulino A, Screpanti I. Felli MP, et al. Int Immunol. 1999 Jul;11(7):1017-25. doi: 10.1093/intimm/11.7.1017. Int Immunol. 1999. PMID: 10383933 - Notch signalling pathway and human diseases.
Joutel A, Tournier-Lasserve E. Joutel A, et al. Semin Cell Dev Biol. 1998 Dec;9(6):619-25. doi: 10.1006/scdb.1998.0261. Semin Cell Dev Biol. 1998. PMID: 10075489 Review. - Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.
Liu H, Chiang MY, Pear WS. Liu H, et al. Int J Hematol. 2011 Aug;94(2):118-125. doi: 10.1007/s12185-011-0899-3. Epub 2011 Aug 5. Int J Hematol. 2011. PMID: 21814881 Review.
Cited by
- NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.
Kroeze E, Kleisman MM, Kester LA, Scheijde-Vermeulen MA, Sonneveld E, Buijs-Gladdines JGC, Hagleitner MM, Meyer-Wentrup FAG, Veening MA, Beishuizen A, Meijerink JPP, Loeffen JLC, Kuiper RP. Kroeze E, et al. Hemasphere. 2024 Jun 27;8(7):e117. doi: 10.1002/hem3.117. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38948925 Free PMC article. - Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
Pan Y, Cengiz R, Kluiver J, Diepstra A, Van den Berg A. Pan Y, et al. Cancers (Basel). 2024 Mar 12;16(6):1126. doi: 10.3390/cancers16061126. Cancers (Basel). 2024. PMID: 38539461 Free PMC article. Review. - Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study.
Papoudou-Bai A, Koumpis E, Karpathiou G, Hatzimichael E, Kanavaros P. Papoudou-Bai A, et al. Diseases. 2024 Feb 29;12(3):51. doi: 10.3390/diseases12030051. Diseases. 2024. PMID: 38534975 Free PMC article. - Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
Santisteban-Espejo A, Bernal-Florindo I, Montero-Pavon P, Perez-Requena J, Atienza-Cuevas L, Fernandez-Valle MDC, Villalba-Fernandez A, Garcia-Rojo M. Santisteban-Espejo A, et al. Int J Mol Sci. 2024 Feb 20;25(5):2457. doi: 10.3390/ijms25052457. Int J Mol Sci. 2024. PMID: 38473705 Free PMC article. - Influence of copper(I) nicotinate complex on the Notch1 signaling pathway in triple negative breast cancer cell lines.
Abdel-Mohsen MA, Badawy AM, Abu-Youssef MA, Yehia MA, Abou Shamaa LD, Mohamed SA. Abdel-Mohsen MA, et al. Sci Rep. 2024 Jan 30;14(1):2522. doi: 10.1038/s41598-024-52952-1. Sci Rep. 2024. PMID: 38291201 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous